The Macular Minute Episode 4
with Serena Salvatore
Patient Experiences with EYLEA® (aflibercept) 8 mg
In this 5-minute episode, we are joined by Serena Salvatore, a Consultant Ophthalmologist at University Hospitals Bristol and Weston NHS Foundation Trust, to discuss patient experiences with EYLEA 8 mg in clinical practice.
This promotional podcast series has been organised and funded by Bayer and is for UK healthcare professionals only.
Prescribing information for EYLEA® (aflibercept) 8 mg can be found here.
Prescribing information for EYLEA® (aflibercept) 2 mg can be found here.
Serena Salvatore
Miss Serena Salvatore was appointed as a consultant in Medical Retina at University Hospitals Bristol and Weston in 2017. In her role, she provides expert care to patients with retinal disorders, employing state-of-the-art diagnostic techniques and evidence-based treatments. She is highly regarded for her empathetic approach, ensuring her patients receive personalised attention and comprehensive management plans tailored to their unique needs. She is dedicated to fostering innovation within healthcare with a human-centric approach. She is actively involved in research and teaching, and her commitment to excellence has earned her the respect of her colleagues and patients.
Speaker Disclosures
Advisory board and speaker fees: Bayer, Roche
Travel bursary and speaker fees: Alimera sciences
References
- EYLEA® 40 mg/mL Summary of Product Characteristics.
- EYLEA® 114.3 mg/mL Summary of Product Characteristics.
PP-EYL-GB-2544 | December 2024